How Much Is Nurse Worth?

$95-135 million

Last updated: June 26, 2026

Quick Facts

Last Sale
$95.4M (2015, Christie's New York)
Methodology
recent sale

This valuation is anchored to the confirmed Christie’s sale of Roy Lichtenstein’s Nurse (1964) on 2015-11-09 for $95,365,000 and adjusted for present‑day market conditions and scarcity. Given the work’s canonical status (RLCR 931), museum‑quality provenance and the structure of evening‑sale demand, a reasonable present market band is $95–135M.

Nurse

Nurse

Roy Lichtenstein, 1964 • Acrylic, oil, and graphite on canvas

Read full analysis of Nurse

Valuation Analysis

Anchor and approach: The primary anchor for this valuation is the verified Christie’s New York sale of Nurse (1964) on 9 November 2015, which realized $95,365,000 (final price with premium) [1]. The work is documented in the Roy Lichtenstein catalogue raisonné (RLCR 931), confirming authenticity and catalogue status [2]. For a high‑end blue‑chip work where a recent, high‑profile sale exists, the most defensible methodology is to use that realized price as the baseline and then adjust for intervening macro and market factors: inflation, continued collector/institutional demand for canonical 1960s Lichtenstein paintings, and any change in the work’s condition, provenance or exhibition record.

Quantitative adjustment and range rationale: The 2015 result provides the unambiguous low floor for a like‑for‑like sale in similar circumstances (major evening sale, full marketing, single‑owner provenance). A simple inflationary uplift from November 2015 to mid‑2026 (used here as a sanity check) places that figure near the low‑to‑mid $100M range; market premium for sustained demand and scarcity can lift the painting well above that uplift. Accordingly I set the present market band at $95–$135 million. The lower bound equals the documented 2015 realization and reflects a conservatively anchored baseline; the upper bound assumes reappearance in an evening auction with top‑tier promotion, multiple competing buyers (including institutions), and clean condition/provenance.

Upside and downside drivers: Upside drivers include: (1) replication of 2015 sale conditions (evening sale, guarantee, global marketing); (2) demonstration of pristine, unrestored surface and strong technical documentation; and (3) renewed institutional interest leading to competitive bidding. Downside risks that would push value below the low end include: significant conservation concerns, undisclosed title or export encumbrances, or a sale in a lower‑visibility channel (day sale, regional auction, or private sale without competitive tension).

Practical considerations: Before marketing, confirm RLCR entry and secure a full conservator’s report, high‑resolution photography, provenance documentation (gallery invoices, previous sale records) and an exhibition/bibliography list. These materials materially influence whether the painting will trade at the lower‑end floor (close to the 2015 result) or command a premium at the high end. Specialist pre‑sale advisement from Christie’s/Sotheby’s/Phillips and contact with the Roy Lichtenstein Foundation for provenance/exhibition notes is recommended.

Conclusion: Because Nurse is a documented, catalogue‑rated 1964 Lichtenstein that set the artist’s auction high in 2015, the most defensible present‑day valuation band is $95–135M, with movement within that band determined by sale channel, the condition report, and pre‑sale marketing/exhibition. The Christie’s 2015 result remains the key market datum and the primary basis for this estimate [1][2].

Key Valuation Factors

Art Historical Significance

High Impact

Nurse (1964) sits within Lichtenstein’s core early/mid‑1960s Pop period, when his engagement with comic imagery, Ben‑Day dot technique and painted speech balloons crystallized. While other canvases (e.g., Whaam!, Drowning Girl) are more instantly iconic in public consciousness, Nurse is nonetheless a firmly canonical work: executed at the height of his pop period, it demonstrates Lichtenstein’s formal language and cultural critique. The RLCR listing (RLCR 931) confirms its place in the corpus. Because scholarship and museum interest focus intensely on canonical 1963–1966 Lichtensteins, art‑historical significance here is a material value driver: institutional buyers prize this period, and that underlies the painting’s ability to command top‑tier prices.

Provenance & Exhibition History

High Impact

The documented chain—Castelli gallery origins, inclusion in the Karl Ströher collection, ownership by Peter Brant and clear auction records—provides exceptional provenance. Provenance of this quality reduces buyer risk, supports institutional acquisition, and increases competitive bidding at auction. Public exhibition and bibliography (where present) further strengthen museum eligibility and marketplace confidence; these elements were key to the successful Christie’s evening sale in 2015. Clean, well‑documented provenance often underwrites premium pricing for canonical works because it verifies authenticity and public visibility.

Condition & Conservation

High Impact

Condition is pivotal for Lichtenstein canvases where surface uniformity and the integrity of Ben‑Day dot application are central to visual and technical value. Any significant restoration, inpainting, overcleaning or structural damage can materially reduce price (often by large percentages on major works). Conversely, a pristine original surface with supportive technical documentation and conservator’s report will preserve or enhance value. Before marketing, a full condition report with high‑resolution imaging and pigment/ground analysis is essential; bidders and institutions demand this level of certainty for nine‑figure purchases.

Rarity & Market Demand

High Impact

True museum‑quality Lichtenstein canvases from 1963–1965 are finite and infrequently offered. That scarcity combined with enduring institutional and private collector demand concentrates purchasing power when a major example appears. Regional demand variations exist, but blue‑chip appetite for canonical Pop works remains robust. The market’s willingness to pay top dollar for rare, well‑documented works amplifies upside; limited supply at the top end keeps competitive tension high in evening sales and curated single‑owner events.

Sale Context & Marketing

High Impact

How the work is sold strongly influences final price. The 2015 Christie’s evening sale was heavily marketed and structured to maximize competition—factors that helped produce the record result. Evening sale placement, guarantees, single‑owner status, pre‑sale museum loan/exhibition and targeted private‑client outreach materially increase the likelihood of realizing the top of the range. Conversely, sale in a lower‑visibility venue or without professional marketing typically results in significantly lower outcomes.

Sale History

Price unknownInvalid Date

Leo Castelli Gallery

Price unknownInvalid Date

Karl Ströher collection (Germany)

Price unknownJanuary 1, 1989

Private acquisition (Peter Brant)

Price unknownMay 2, 1995

Sotheby's, New York

Price unknownNovember 9, 2015

Christie's, New York (The Artist's Muse evening sale, Lot 13A)

Roy Lichtenstein's Market

Roy Lichtenstein is a blue‑chip postwar/pop artist whose canonical mid‑1960s canvases are among the most sought after in the secondary market. He benefits from sustained institutional collecting, prominent catalogue raisonné scholarship and periodic high‑profile sales that set market anchors. While later works trade at lower price points, museum‑quality 1963–1966 paintings perform strongly at major houses; headline results and scarcity reinforce collector confidence and price resilience.

Comparable Sales

Nurse

Roy Lichtenstein

Direct, documented sale of the same painting — the auction record and the primary ceiling/anchor for valuation. Result reflects exceptional evening‑sale conditions, guaranteed lot and single‑owner provenance.

$95.4M

2015, Christie's New York

~$128.2M adjusted

Nude with Joyous Painting

Roy Lichtenstein

High‑profile evening‑sale result for a museum‑quality Lichtenstein (1994) showing buyer willingness to pay tens of millions; useful as an upper‑mid market benchmark though a later‑period work and therefore less historically significant than a 1964 Nurse.

$46.2M

2020, Christie's New York

~$53.6M adjusted

Interior: Perfect Pitcher

Roy Lichtenstein

Evening‑sale example (1994) selling in the mid‑tens of millions; indicates where high‑quality Lichtensteins without ultra‑rare provenance commonly price in recent years.

$22.7M

2021, Christie's New York

~$25.5M adjusted

Reflections on Thud!

Roy Lichtenstein

Sotheby's Hong Kong result (1990) showing regional demand and pricing in the low‑double‑digits; helpful to bracket the market's lower‑mid level for quality works.

$14.2M

2021, Sotheby's Hong Kong

~$16.0M adjusted

Rouen Cathedral, Set IV

Roy Lichtenstein

Late‑1960s Lichtenstein (1969) — closer in period to Nurse and a useful recent benchmark for mid/late‑1960s works; sold in a major sale and therefore directly relevant to period comparables.

$15.4M

2023, Christie's New York

~$16.3M adjusted

Nude

Roy Lichtenstein

Phillips sale (1997 work) at lower‑profile house and price point — useful to define the lower bound for strong market examples (post‑1990s works) and to bracket expected ranges.

$10.3M

2022, Phillips New York

~$11.3M adjusted

Current Market Trends

The high end of the modern and postwar market has remained relatively resilient: top‑tier canonical works continue to attract competitive bidding when offered with strong provenance and marketing. Macro volatility and regional demand cycles add uncertainty, but scarcity of museum‑quality 1960s Lichtensteins and institutional interest support robust pricing for works like Nurse.

Study print

Study this painting as a print

Pair the full artwork with a museum-style study sheet focused on one meaningful detail.

Disclaimer: This estimate is for informational and educational purposes only. It is based on publicly available data and AI analysis. It should not be used for insurance, tax, estate planning, or sale purposes. For formal appraisals, consult a certified appraiser.

Explore More by Roy Lichtenstein

More valuations by Roy Lichtenstein